AGYS.NASDAQAgilysys INC

Form 4: Agilysys Director Melvin L. Keating Sells Shares in Recent Transactions

Sentiment:

SEC Form 4 Filing


Director Melvin L. Keating of Agilysys Inc. [AGYS] recently sold a portion of his holdings in two separate transactions.

Summary

  • On November 6, 2024, Melvin L. Keating, a director of Agilysys Inc., sold 3,500 shares of common stock at a weighted average price of $114.19.
  • The prices for the November 6th sale ranged from $112.22 to $115.70.
  • Following this transaction, Keating beneficially owned 41,507 shares.
  • On November 7, 2024, Keating sold an additional 1,920 shares at a weighted average price of $117.55.
  • The prices for the November 7th sale ranged from $116.16 to $118.18.
  • After the second transaction, Keating's beneficial ownership decreased to 39,587 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock sales by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.

Industry Context

This Form 4 filing is a routine disclosure of stock transactions by a company insider. It's common for directors and officers to buy or sell shares of their company's stock, and these transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

  • Shareholders may interpret the stock sales as a signal, although insider sales are not always indicative of negative sentiment.
  • The transactions have a minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
11/06/2024Director Melvin L. Keating sold 3,500 shares of Agilysys Inc. common stock.
11/07/2024Director Melvin L. Keating sold 1,920 shares of Agilysys Inc. common stock.
11/12/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.